Beit Jala Pharmaceutical Balance Sheet Health
Financial Health criteria checks 6/6
Beit Jala Pharmaceutical has a total shareholder equity of JOD13.8M and total debt of JOD941.1K, which brings its debt-to-equity ratio to 6.8%. Its total assets and total liabilities are JOD17.9M and JOD4.1M respectively. Beit Jala Pharmaceutical's EBIT is JOD2.3M making its interest coverage ratio 20.2. It has cash and short-term investments of JOD1.3M.
Key information
6.8%
Debt to equity ratio
د.أ941.06k
Debt
| Interest coverage ratio | 20.2x |
| Cash | د.أ1.34m |
| Equity | د.أ13.77m |
| Total liabilities | د.أ4.08m |
| Total assets | د.أ17.85m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: BJP's short term assets (JOD8.9M) exceed its short term liabilities (JOD2.1M).
Long Term Liabilities: BJP's short term assets (JOD8.9M) exceed its long term liabilities (JOD1.9M).
Debt to Equity History and Analysis
Debt Level: BJP has more cash than its total debt.
Reducing Debt: BJP's debt to equity ratio has reduced from 14.7% to 6.8% over the past 5 years.
Debt Coverage: BJP's debt is well covered by operating cash flow (207.6%).
Interest Coverage: BJP's interest payments on its debt are well covered by EBIT (20.2x coverage).